欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0135/003
药品名称
Milbemax tablets for Small Cats and Kittens
活性成分
milbemycin A<3>-oxim 4.0 mg
PRAZIQUANTEL 10.0 mg
剂型
Tablet
上市许可持有人
Novartis A.H.
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Milbemax Vet. (små katte og killinger)
Belgium (BE)
Milbemax filmomhulde tabletten voor kleine katten en kittens
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Milbemax- Tabletten fuer kleine Katzen und Katzenwelpen ab 0,5 k
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
Greece (GR)
Poland (PL)
Hungary (HU)
Cyprus (CY)
Czechia (CZ)
Slovakia (SK)
Slovenia (SI)
MILBEMAX za majhne mačke in mačje mladiče
许可日期
2003/04/17
最近更新日期
2025/07/31
药物ATC编码
QP54AB51 milbemycin oxime, combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full Dossier (art.5)
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
Final SmPC _ Milbemax kitten
Date of last change:2024/09/06
Final Product Information
|
Milbemax_fcTablets_SmallCat_en_MRP_QRD_clean_Final
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase